The impact of genetic alterations in NSCLC centers around genes encoding receptor tyrosine kinases (RTKs), whose activation leads to a heightened proliferation, survival, migration, and invasion of cancer cells. This evidence concerns the gene NTRK1 and non-small cell lung carcinoma.